The surgical management of 168 consecutive patients harboring craniopharyngiomas treated between January 1983 and April 1997 is described. In 148 patients undergoing initial (primary) surgery, the pterional approach was most frequently used (39.2%) followed by the transsphenoidal approach (23.6%). For large retrochiasmatic craniopharyngiomas, the bifrontal interhemispheric approach was used increasingly over the pterional approach and led to improved surgical results. Total tumor removal was accomplished in 45.7% of transcranial and 85.7% of transsphenoidal procedures. The main reasons for incomplete removal were attachment and/or infiltration of the hypothalamus, major calcifications, and attachment to vascular structures. The success rate in total tumor removal was inferior in the cases of tumor recurrence. The operative mortality rate in transcranial surgery was 1.1% in primary cases and 10.5% in cases of tumor recurrence. No patient died in the group undergoing transsphenoidal surgery. The rate of recurrence-free survival after total removal was 86.9% at 5 years and 81.3% at 10 years. In contrast, the 5-year recurrence-free survival rate was only 48.8% after subtotal removal and 41.5% after partial removal. Following primary surgery, the actuarial survival rate was 92.7% at 10 years, with the best results after complete tumor removal. At last follow up, 117 (79%) of 148 patients who underwent primary surgery were independent and without impairment.
Particularly for patients with these tumors, the preferred approach and the extent of surgery vary--not only when series of patients treated by different neurosurgeons are compared but also within an individual neurosurgeon's lifetime experience of managing these lesions. Because the majority of all craniopharyngiomas involve the hypothalamus, which is one of the most important structures in the brain, higher mortality and morbidity rates have been reported following the attempt of radical surgery. [9, 42] Several authors have reported a high recurrence rate despite apparently complete tumor removal. These observations provided a strong argument for the therapeutic concept of limited surgery plus radiotherapy. [9, 28] However, the usefulness of results derived from earlier surgical series is limited in developing guidelines for current management of craniopharyngiomas. Series that include patients treated in the microsurgical era are not comparable to the standard of today. Investigators in some of the more recent surgical series have reported low morbidity and mortality rates when performing transcranial microsurgical removal of craniopharyngiomas [32, 36] even when an attempt is made to remove the tumors totally. Previously, the claim of a total removal was based on the surgeon's intraoperative impression, which alone, is no longer sufficient. [7, 8, 36, 39] Today, postoperative imaging is required to define complete removal. The advent of postoperative imaging might explain why the recurrence rates in more recent surgical series appear more favorable than previously reported. [8, 32, 36, 42] To elucidate the current role of surgery in the management of craniopharyngiomas, we have assessed the outcome results in a consecutive series of 168 patients treated by surgery since 1983.
CLINICAL MATERIAL AND METHODS

Patient Population
Between January 1983 and April 1997, 168 patients (80 females and 88 males) harboring craniopharyngiomas underwent surgery in our department. Of these 168 patients, 148 (118 adults and 30 children) had not undergone previoius surgery or other therapy. A second open surgical procedure was required in 14 of these patients. The remaining 20 patients had undergone surgery previously in other centers and were referred for treatment of a recurrent tumor. The transcranial operations and the majority of transsphenoidal operations were performed by one author (R.F.). The remaining operations were performed by two of the other authors (M.B. and J.H.), and stereotactic procedures were performed by the neuroradiologist (W.H.). Our experience also includes additional patients in whom no surgery was performed but they should be mentioned to illustrate the full spectrum of patients referred to our department for treatment. We have seen approximately 10 patients with small, asymptomatic tumors that raised suspicion of craniopharyngiomas; these patients were kept under observation. We are only aware of one patient who harbored a large, calcified, nonprogressive craniopharyngioma who was not surgically treated.
Pathological Classification
Often, epithelial cystic lesions cannot be definitely categorized and overlapping of histological characteristics is encountered. [11] For this reason, all available tumor specimens were reviewed by a neuropathologist (W.P.). All cases suggestive of Rathke's cysts or other diseases were excluded. In seven cases, examination of the specimens did not lead to a definite pathological diagnosis; however, the clinical and neuroradiological features and the intraoperative findings were clearly consistent with craniopharyngiomas. These patients were included in this study. In all other cases, specimen examination provided a definite diagnosis of a craniopharyngioma. In 15% of the cases, the histological characteristics of the craniopharyngiomas were of the papillary type and in 85% the adamantinomatous type.
Neuroradiological Evaluation
In all patients, plain skull x-ray films were available. Preoperative work-up tests included computerized tomography (CT) scanning and, since 1987, MR imaging.
For measurement of tumor size, diameters in three planes (a, b, and c) were calculated on the basis of MR (or CT) images. Tumor volume has approximately the volume of an ellipsoid with the diameters a, b, and c. From the ellipsoid shape, a spherical shape with the same volume and a diameter (d) can be calculated. Assuming a spheric shape the tumor diameter was calculated as: d = (abc) 1/3 .
Three months after surgery, all patients were reassessed by MR and/or CT imaging except for three patients who died in the postoperative period and one patient who refused early postoperative reassessment. From 1987, complete tumor removal was documented by using contrast-enhanced MR imaging in all but six patients in whom only contrast-enhanced CT scanning was performed. In all cases, findings on postoperative MR and/or CT imaging were interpreted by the authors.
Ophthalmological Evaluation
Ophthalmological evaluation included tests of visual acuity and perimetry in older children and adults, whereas appropriate clinical tests were applied in young children. The patients were examined preoperatively and at 1 week and 3 months after surgery. In nine patients, complete assessment of visual function was precluded either because of a reduced preoperative mental state or because of postoperative mortality or disabling morbidity. Thus, we were able to obtain complete preoperative and postoperative data for 159 of the 168 patients from the Department of Ophthalmology.
Endocrinological Evaluation
The patients underwent sophisticated preoperative and postoperative endocrinological evaluation. The endocrine aspects of the cases are reported in Part II of this paper presented in this issue of Neurosurgical Focus.
Follow-Up Evaluations
The first follow-up examination, which took place 3 months after surgery, was regularly performed on an inpatient basis. Thereafter, most patients were regularly seen by one of the authors (J.H., M.B., or R.F.) in our outpatient department. Some patients were also followed by physicians at their referring centers and data were obtained from their medical reports. The mean follow-up period was 64.8 months (median 55.5 months; maximum 175 months). Records from follow-up examinations held until August 1997 were used to ensure that all patients had completed their first follow-up examination.
RESULTS
Clinical Features
Among the 148 patients who underwent initial surgery at our institution (primary surgery), the mean age was 36.6 years (range 1-79 years). The patient age distribution (grouped into 5-year increments) showed a peak incidence between 15 and 20 years (Fig. 1) . Another peak was found between 50 and 55 years. Thirty patients were children aged less than 16 years at the time of surgery. Presenting Symptoms. The most frequent major presenting symptom was visual impairment followed by endocrine deficiency. Forty-seven percent of the patients sought medical attention because of visual compromise. Symptoms related to hydrocephalus and nonspecific headaches occurred more frequently in children than in adults. These symptoms were the presenting complaint in 16.7% and 13.3% of the children, respectively. Neurological symptoms were relatively uncommon.
Ophthalmological Findings. Formal ophthalmological evaluation revealed visual compromise in 74.5% of the patients at the time the diagnosis of a craniopharyngioma was initially made. A chiasma syndrome was found in 76.8% of adult patients and occurred less frequently in children. Only 65.6% of the children suffered from visual impairment. In the group of patients scheduled for transcranial surgery, the percentage of chiasma syndrome was 84.3%; this clearly surpassed the 42.9% okf chiasma syndrome in patients scheduled transsphenoidal surgery (Table 1) . Visual impairment was found in 83.3% of patients with recurrent craniopharyngiomas. The percentage of visual compromise was much higher in cases of recurrent tumors than in primary cases, particularly in patients who were scheduled for transsphenoidal surgery.
Neuroradiological Findings. At the time of the initial diagnosis, the numbers of craniopharyngiomas were almost equally distributed throughout the 1-to <2-cm, 2-to <3-cm, and 3-to <4-cm size catagories (Table 2) . No tumor in our operative series was less than 1 cm in diameter and 13.5% of the craniopharyngiomas were larger than 4 cm. On average, the subgroup of tumors suitable for transsphenoidal surgery had smaller sizes; 60% of them were 1 to <2 cm in diameter. Only one tumor treated via transsphenoidal approach was larger than 4 cm. On average, craniopharyngiomas requiring transcranial surgery were larger than those requiring transsphenoidal surgery, and 13 exceeded 4 cm in diameter.
Tumor calcifications were encountered in 57.4% of the craniopharyngiomas at the time of diagnosis. At 83.3%, the percentage of calcifications was much higher in children. Calcification was found in 64.7% of recurrent craniopharyngiomas.
Enlargement of the pituitary fossa was found in 69 (46.6%) of the 148 cases. In the group of 94 patients who underwent primary transcranial surgery, the pituitary fossa was enlarged in 34 (36.2%). In contrast, the pituitary fossa was enlarged by the craniopharyngioma in 32 (91.4%) of the 35 patients who underwent primary transsphenoidal surgery with slight enlargement in 57.1% and marked enlargement in 34.3%.
Approximately one-half of the newly diagnosed craniopharygniomas were predominantly cystic (Table  3) . Purely cystic craniopharyngiomas were encountered in only 3.4% of the patients. The percentage of predominantly or solely solid craniopharyngiomas was as high as 39.2%. In children, the percentage of predominantly cystic and multicystic craniopharyngiomas was slightly higher than in the mixed series. The composition of recurrent craniopharyngiomas was similar to primary craniopharyngiomas.
Surgical Approaches
Pterional Approach. The pterional approach was most frequently used in our series. It was exclusively applied in 39.2% of the cases ( Table 4 ). The pterional approach provides a short distance to the suprasellar region. The sylvian fissure is opened in cases of larger tumors. The craniopharyngioma is generally removed through the opticocarotid triangle and through the prechiasmatic space.
The pterional approach also allows access to the third ventricle through the lamina terminalis to remove craniopharyngioma tissue from the lower and anterior third ventricle. Early in our series, we used the pterional approach for all craniopharyngiomas located in the chiasmatic and interpeduncular cisterns. However, we found that the pterional approach has certain limitations. The surgical corridor is narrow in the case of an anteriorly positioned optic chiasm. Furthermore, the lateral view through the opticocarotid triangle may be hindered by perforating arteries. Even today, the course of these vessels cannot be predicted by viewing preoperative imaging studies. A large retrosellar craniopharyngioma is insufficiently visualized by the pterional approach. Consequently, some of our tumors were incompletely removed when we used this approach because of the surgeon's restricted view (Table 5) . Therefore, in recent years, we have increasingly used the bifrontal interhemispheric approach. The pterional approach is now applied in cases of small craniopharyngiomas.
Bifrontal Interhemispheric Approach. In our department, the first bifrontal interhemispheric approach used to treat a craniopharyngioma was performed in 1991. Since that time, a total of 28 bifrontal operations have been performed.
For the bifrontal interhemispheric approach, it is critical that the craniotomy is extended to the level of the frontal base and the frontal sinus is deliberately opened. This procedure allows minimum brain retraction. The olfactory nerves are microscopically freed from their arachnoid attachments. The frontal lobes and the anterior cerebral arteries are gently retracted. The craniopharyngioma is exposed and removed from the prechiasmatic area. Cystic lesions are decompressed by opening the capsule.
Retrochiasmatic exposure is started by creating a midline incision in the lamina terminalis. If the third ventricle is elevated but not invaded by the craniopharyngioma, the thin tissue layer of the distended lamina terminalis is incised without opening the third ventricle. Having exposed the craniopharyngioma, it is debulked within the capsule for decompression so that the capsule can be gently removed from the surrounding structures. Perforating vessels are stripped away and the capsule is bluntly removed from the surrounding reactive gliotic layer or from the arachnoid covers. The exposure allows an excellent view into the retrosellar space. Using direct view, the craniopharyngioma is removed from the mesencephalon, from the distal basilar artery, and from the proximal posterior cerebral arteries. Craniopharyngiomas with a prepontine extension can be exposed and removed; to a certain degree, some cystic craniopharygniomas that extend into the cerebellopontine angle can be dealt with similarly. The operative view is not hindered by perforating vessels. In our experience, it is the best approach for resecting large retrochiasmatic and suprasellar craniopharyngiomas.
Craniopharyngiomas that invade the third ventricle are exposed through the lamina terminalis. The bifrontal interhemispheric approach provides excellent midline orientation and the displaced floor of the opened third ventricle is exposed. Therefore, this approach is superior to the pterional approach if major intraventricular tumor extension is anticipated. Pure intraventricular craniopharyngiomas are relatively rare. Most tumors that have intraventricular extension have created an opening in the basal hypothalamus. Through this preexisting defect, the extraventricular portion can be removed.
During retrochiasmatic removal, care must be taken to avoid damage to the optic pathways. Despite this manipulation close to the chiasm, only a slightly greater rate of our patients (20%) suffered visual deterioration following the bifrontal approach than the overall rate of visual deterioration (14.6%) during transcranial surgery.
Transventricular and Transcallosal Approaches. The transventricular or transcallosal approach was used as the only surgical procedure in six of our patients. Both approaches are suitable for resecting craniopharyngiomas in the upper third ventricle that extend to the foramen of Monro. Enlargement of the lateral ventricle facilitates tumor removal through the foramen. Some craniopharyngiomas extend through the foramen of Monro into the lateral ventricle. In one of our cases, a craniopharyngioma with such an extension was surgically treated via a transventricular approach. The approach followed the extension of the tumor through the third ventricle downward into the enlarged pituitary fossa and the tumor was removed. Minor solid remnants that were found to be infiltrating the wall of the third ventricle remained stable at a follow-up period of 3 years.
Combined Approaches. Twelve patients (8.1%) were surgically treated via combined approaches (that is, two open surgical procedures performed in two sittings) ( Table 4 ). The intervals between the operations ranged from 4 days to a few months. In seven of these cases, a combined approach was initially planned. In three cases, the necessity of an additional procedure was obvious during the first operation; in the remaining two cases, the second operation was planned after evaluation of postoperative MR imaging.
In six patients, the first operation was performed via a superior (transventricular or transcallosal) approach. The aim was to prevent and treat hydrocephalus by removal of the craniopharyngioma at the level of the foramen of Monro and to remove the intraventricular potion of the tumor. The extraventricular portion of the tumor was excised during the second operation. Preoperative and postoperative MR images of a craniopharyngioma that was removed by a combined transventricular-bifrontal interhemispheric approach are demonstrated in Fig. 2 . In two cases, a pterional approach preceded transventricular surgery to initially relieve a severe chiasma syndrome. A transsphenoidal operation was required after pterional surgery in three cases to excise a residual intrasellar portion of tumor. (Table 4) . Transsphenoidal surgery is suitable for resecting "subdiaphragmatic" craniopharyngiomas arising from the pituitary fossa. An intrasellar location for the tumor with enlargement of the pituitary fossa and a rounded and symmetrical suprasellar extension suggests a subdiaphragmatic craniopharyngioma. In our department, we place the patient in a supine position. Generally, a sublabial (or per nasus), paraseptal approach was chosen.
Transsphenoidal surgery for craniopharyngiomas is more difficult than surgery for pituitary adenomas. For this reason, a wide exposure and a large opening in the sphenoid sinus and sellar floor is mandatory. It enables sufficient illumination and improved handling of the tumor. The main problems encountered with this approach are as follows: 1) The pituitary gland is displaced ventrally in more than 50% of cases. Splitting of the gland at the midline is required for craniopharyngioma exposure. The pituitary is gently pushed laterally. Careful handling is required to avoid additional endocrine deficiency. The lateral view of the craniopharyngioma is impaired by the position of the pituitary gland. 2) If present, the craniopharyngioma capsule may firmly adhere to the pituitary stalk from which the lesions often originate. Therefore, sharp excision from the stalk is sometimes required.
3) The capsule is firmly attached to the diaphragm and sharp excision from the diaphragm is required in certain cases. In some, removal is only accomplished if a portion of the diaphragm is excised with the adhering capsule. Furthermore, the craniopharyngioma is only separated from the intradural space by a thin arachnoidal layer in some cases. The reason might be an origin of the craniopharyngioma at the level of the sellar entrance with a consecutive defect of the diaphragm. Therefore, an intraoperative cerebrospinal fluid (CSF) leak is frequently observed or deliberately produced. In our series, an intraoperative CSF leak was encountered in 28 (80%) of 35 primary cases. The leakage was sealed in each case by using fascia from the thigh and fibrin glue as a sealant. The sphenoid sinus was additionally packed with Gelfoam and an additional piece of fat from the thigh in cases in which there was a severe leak. In the case of an intraoperative leak, a lumbar drainage system was inserted while the patient was in the operating room and 15 to 20 ml of CSF were withdrawn three times daily over a 4 to 6 day period.
Stereotactic Cyst Decompression. In 14 cases, stereotactic cyst decompression preceded definite craniopharyngioma removal. Stereotactic cyst drainage was used in cases of craniopharyngiomas with major cystic portions and, particularly, if the patients presented with clinical signs of severe hypothalamic derangement or severe (progressive) visual loss.
In most of these cases, a catheter passing through the lateral ventricle was implanted into the cyst and connected to a subcutaneous Rickham reservoir. Perforations at the level of the lateral ventricle allowed spontaneous drainage of the cyst. No meningeal reactions were observed by using this method. Significant visual improvement was observed after cyst decompression in most patients. Once the cyst was collapsed, the craniopharyngioma was retracted from the brain tissue and consecutive removal of the solid portion was facilitated. Figure 3 demonstrates such a cystic craniopharyngioma before and after cyst decompression and after tumor removal. We have also observed improvement in hypothalamic signs, such as disturbed state of sleep and wakefulness, after cyst decompression. Following cyst drainage with decompression of hypothalamic structures, we also anticipated a reduced risk of subsequent surgical tumor removal. After cyst decompression, a basal approach was usually sufficient and an additional initial superior approach could be avoided in individual cases. We have observed refilling of the cyst despite insertion of a permanent drainage catheter when the final procedure was delayed for a few months. Therefore, we now recommend that transcranial tumor removal be performed 1 to 4 weeks after stereotactic cyst decompression. Fig. 3 . Coronal and sagittal contrast-enhanced MR images obtained in a patient who had a predominantly cystic craniopharyngioma. The images were obtained at presentation (A and B), after stereotactic cyst decompression (C and D), and after removal of the solid portion and capsule of the tumor via a pterional approach (E and F).
Nineteen patients did not undergo open surgery; 14 of these patients underwent stereotactic cyst decompression only (Table 4) . This group of patients was mainly composed of elderly patients with risk factors and/or large cystic craniopharyngiomas; however, one patient who exhibited severe hypothalamic signs at presentation was also included.
Approaches Used in Patients With Recurrent craniopharyngioma.
Patients who experienced tumor recurrence most frequently underwent surgery via a transsphenoidal approach (Table 6 ). Similar to primary surgery, in operation for recurrent tumor the pterional approach was most frequently used in transcranial procedures followed by the bifrontal interhemispheric approach.
Extent of Tumor Removal
Tumor removal was considered complete if the surgeon was convinced that there had been complete removal and if postoperative contrast-enhanced MR imaging (or early in the series contrast-enhanced CT scanning) showed no evidence of residual tumor. Removal was considered subtotal when only a small potion of residual tumor remained because of firm attachment to vascular or neural structures or when postoperative imaging revealed a small contrast-enhancing or calcified area. Partial removal was defined as the presence of a larger residual portion of tumor.
In the total series, 49.3% of craniopharyngiomas were completely removed (Table 7) . In four additional cases, the surgeon had the impression of a total removal, but postoperative imaging performed after 3 months demonstrated residual tumor (Table 5 ). These four craniopharyngiomas appear in the category of subtotally removed craniopharyngiomas. Subtotal removal was accomplished in 22.3% of all craniopharyngiomas. In children, the rate of complete tumor removal was slightly less (43.3%) than that of the total series; however, an additional 36.7% of childhood craniopharyngiomas were subtotally resected ( Table 7) .
The percentage of total removal was 45.7% during transcranial procedures (Table 8) . Subtotal removal was achieved in another 30.9%, partial removal in 21.3%, and cyst decompression with biopsy of the capsule in 2.1%. The highest success rate was achieved in transsphenoidal surgery, with complete removal in 85.7% of the primary cases, subtotal removal in another 11.4%, and partial removal in 2.9%. The success rate of total removal dramatically dropped in recurrent craniopharyngiomas. Only 21.1% of recurrent tumors were completely removed during transcranial procedures. Those recurrent craniopharyngiomas that were suitable for transsphenoidal surgery were completely removed in 53.4% of the cases.
Among the transcranial approaches, the bifrontal interhemispheric approach allowed complete resection in 58.8% of the cases ( Table 9 ). The success rate of total removal was slightly lower with the use of the pterional approach. The lowest rate of complete tumor removal was achieved during combined approaches. This can be explained by the selection of large tumors for a combined procedure.
The presence of hydrocephalus, tumor within the third ventricle, and a rate of more than 10% calcification were highly significant prognostic factors that were negatively correlated with the extent of resection (Table 10 ). Only few cases with third ventricle involvement or major calcifications were completely removed. Hydrocephalus was the most adverse prognostic factor with only 15.8% of craniopharyngiomas being completely removed.
Tumor size was also a significant prognostic factor (Table 11 ). In craniopharyngiomas measuring less than 2 cm in diameter, 88.1% were totally removed and 9.5% were subtotally removed. The rate of complete removal was still 60% in tumors measuring 2 to <3 cm. In contrast, no craniopharyngiomas larger than 4 cm was totally removed.
The reasons for incomplete removal were analyzed according to the patients' surgical records (Table 5) . Firm attachment to the hypothalamus was a frequent reason why the surgical procedure was abandoned. In particular, bilateral hypothalamic damage carries the risk of hypothalamic derangement. Therefore, the surgeon was content with subtotal or partial removal in the case of tight hypothalamic connections because postoperative morbidity and mortality could be avoided. An inadequate view of the tumor and the presence of major calcifications were also relatively common reasons for incomplete tumor removal. In the case of significant calcifications, a particular risk of damage to the hypothalamus, but also to adherent (perforating) vessels or to the optic pathways, must be considered during dissection. In some instances, the area opposite the calcifications is insufficiently visualized and aggressive removal is hazardous. Firm adherence of the tumor capsule to perforating vessels or to large basal arteries is frequently encountered during craniopharyngioma surgery. It is wise to leave minor residual portions of tumor and to settle with subtotal removal if significant attachment to crucial vessels is encountered. Otherwise, vascular damage is anticipated with the attempt at total tumor removal.
Incidences of Morbidity and Mortality
The early surgical mortality rate in patients who underwent primary transcranial and combined surgery was 1.1% (Table 12 ). The one patient who succumbed had a history of heart disease and died of cardiac arrest 2 days after surgery. None of the patients in whom complete tumor removal was accomplished died. The mortality rate after transcranial surgery for tumor recurrence was 10.5%. One patient died of brainstem infarction 39 days after surgery and the other patient died of meningitis 12 days after surgery. None of our patients died during primary or secondary transsphenoidal surgery.
In primary transcranial surgery, the operative morbidity rate was 12.8% (Table 13 ). Most complications were controlled without sequelae. However, two patients suffered severe postoperative hypothalamic dysregulation; these patients remained in a severely disabled state, leaving one partially and the other totally dependent. They finally died 8 and 37 months after surgery, respectively. Therefore, the delayed mortality rate in patients who underwent primary transcranial surgery was 2.1% (two of 94). (These two patients are listed in Table 13 .) The morbidity rate in patients who underwent transcranial surgery for tumor recurrence was 15.8% (Table 13 ). Hypothalamic obesity was no major problem in our series. In some patients, transient postoperative weight gain occurred within the early postoperative months and regressed thereafter. Only two children had long-term problems with obesity.
The surgical morbidity rate in patients who underwent primary transsphenoidal surgery was 5.7% (Table  13) , and the rate in patients who underwent transsphenoidal procedures for tumor recurrence was 13.3% (Table 13 ). All complications of these procedures were cured without sequelae. A nasal CSF fistula found in two cases after transsphenoidal surgery was repaired by additional surgery (Table 13) . No late incidence of morbidity or mortality was observed after transsphenoidal surgery.
Complications were only encountered in adults. None of the children undergoing primary surgery or surgery for recurrence suffered a complication or died as a result of surgery.
Visual Outcome
In primary transcranial surgery, a chiasma syndrome completey regressed in approximately one-third of the patients and in an additional one-third vision was partially recovered (Table 1) . Visual deterioration was found in 14.7% of patients after transcranial surgery. A new postoperative deficit with normal vision at presentation was encountered in only one case. Ophthalmological results were superior in children. Postoperative visual deterioration was not observed in any of the 21 children who underwent transcranial surgery. In cases of recurrent craniopharyngiomas, complete normalization of vision was encountered in only 7.1% after transcranial surgery. This low percentage is explained by a long-standing history in some patients and by a possible damage to the visual pathways by initial surgery. In 57.1% of the patients with recurrences, visual impairment partially regressed postoperatively.
Visual outcome was most favorable in transsphenoidal surgery (Table 1) . In primary surgery, a chiasma syndrome completely normalized in 46.7% of the patients and partially regressed in another 40%. None of the patients experienced visual deterioration after surgery. In transsphenoidal surgery for a recurrent craniopharyngioma, 36.4% of patients had some degree of postoperative improvement in vision but only 18.2% had complete recovery of a chiasma syndrome. One patient who underwent transsphenoidal surgery for a recurrent tumor experienced postoperative visual deterioration. However, this patient underwent a second pterional surgery and appears in the group of patients who underwent combined surgery rather than in the transsphenoidal group.
Radiation Therapy
No patient received radiotherapy prior to the initial surgery and only one patient underwent a course of radiotherapy following complete tumor removal. Three patients received early postoperative radiotherapy after subtotal tumor removal and eight after partial removal. One patient who underwent transcranial cyst decompression and biopsy and five patients who underwent limited surgery obtained radiotherapy immediately after surgery.
In the group of patients who underwent transcranial surgery, 29 (30.9%) received radiotherapy at some stage of the disease. Only one patient who underwent transsphenoidal surgery received radiotherapy. Ten patients (52.6%) who had limited surgery underwent a course of radiotherapy at some stage.
Additional Follow-Up Evaluation
Tumor Recurrence. Recurrence after complete removal of tumor was observed in eight of 72 cases (one additional patient who underwent postoperative radiotherapy was excluded). The cumulative rate of recurrence-free survival was 86.9% at 5 years and 81.3% at 10 years using the Kaplan-Meier estimate (Figure 4) . The latest recurrence following complete tumor removal occurred 71 months after surgery. Thus far, no recurrence has been observed after a transsphenoidal approach was used to achieve complete tumor removal. Five cases of recurrence were observed after a pterional approach, two cases of recurrence after a bifrontal interhemispheric approach, and one case of recurrence after a combined pterional-transsphenoidal approach. Fig. 4 . Graph depicting recurrence-free survival times in patients who underwent primary surgery for craniopharyngioma in relation to the extent of tumor resection (Kaplan-Meier method).
Site of Tumor Recurrence. In five of eight cases of recurrence, the regrowing tumor was found within the pituitary fossa. The sphenoid sinus variant approach [25] to the pituitary fossa was applied in only one of these cases during primary surgery. This observation underlines that exposure of the intrasellar area during transcranial surgery is crucial to prevent recurrences. If there is evidence of intrasellar tumor extension, the pituitary fossa should be exposed through the sphenoid sinus. Four of the recurrent intrasellar tumors were removed via a transsphenoidal approach and one case of a small recurrence is still under observation. One recurrent tumor developed underneath the optic chiasm. The remaining two cases of recurrence showed a pre-and postchiasmatic extension and one of the tumors had invaded the basal hypothalamus at the time of reoperation.
After subtotal tumor removal, the rate of recurrence-free survival was 48.8% (Figure 4) . Surprisingly, all recurrent tumors were encountered early. No recurrence occurred later than 35 months after surgery. The rate of recurrence after partial removal was significantly higher. Nine of 13 patients with partial removal suffered a recurrence. The rate of freedom from recurrence calculated by the Kaplan-Meier method was as low as 15.6%. The correct expression in such cases would be "progression of residual craniopharyngioma;" however, we use the term "recurrence" when comparing results with craniopharyngiomas that were totally removed.
Statistically, recurrence rates after total, subtotal, or partial removal were significantly different (p lt 0.001, log-rank test). Only patients who did not receive postoperative radiotherapy were included.
Management of Tumor Recurrence.
Of the 148 tumors that were treated with primary surgery in our department, 43 recurred during the follow-up period. As mentioned earlier, in 14 of these cases the patients underwent a second operation for tumor recurrence at our institution and one other patient had additional surgery at another center. Fifteen other patients with recurrent tumor required stereotactic cyst decompression. Conventional radiotherapy, in addition to open or stereotactic reoperation, was applied in 18 cases and radiosurgery in one case. Four patients with tumor recurrence underwent conventional radiotherapy only. Two of the patients mentioned above required shunt implantation secondary to recurrence and one other patient only underwent shunt implantation for recurrence. Six other cases of slowly growing recurrent tumor remain under observation. In two patients, no further therapy was offered for tumor recurrence because of advanced disease.
Functional Outcome. At the time of the last follow up, 77.7% of the patients who underwent transcranial surgery were independent and without impairment (Table 14) . Eight of the 94 patients had a certain degree of impairment. Some had difficulties because of reduced vision and some were unable to return to their previous occupation because of reduced efficiency. Five patients were partially dependent. Disease-related deaths observed in this study occurred in patients with some sort of functional disability. In contrast, deterioration of functional status was not observed in those patients who were independent and without impairment 3 months after surgery. Three months after transsphenoidal surgery, all patients were independent and without impairment. Two of these patients died later of intercurrent disease. One patient who had undergone partial transsphenoidal resection later underwent transcranial surgery for tumor recurrence and, subsequently, died of hypothalamic dysregulation. All other patients remained in excellent condition. Of the patients who underwent large surgical procedures (transcranial or transsphenoidal) 81% were leading independent lives with no impairment at the last follow-up review.
After limited surgery, 63.1% of the patients were independent and without impairment 3 months postoperatively and at the last follow up.
Considerable instances of impairment and dependency existed before surgery and sometimes they were not clearly related to the craniopharyngioma. On the other hand, preoperative impairments such as visual failure or acute symptoms from hydrocephalus frequently regressed after surgery. This must be considered in the judgment of functional outcome. However, we believe that a comparison of preoperative and postoperative functional states is complex and too difficult to demonstrate.
Eleven (57.9%) of 19 patients who underwent transcranial surgery for recurrent tumor were independent and without impairment at the last follow-up visit and 15.8% were independent with some difficulties. Following transsphenoidal surgery for recurrence 14 (93.3%) of 15 were patients leading independent lives with no impairment at the time of the last follow-up evaluation. Only one patient in whom the transsphenoidal procedure was palliative died of the disease.
Survival Rates. Nine of 148 patients with newly diagnosed craniopharyngiomas died of the disease during the follow-up period (Table 14) . In three of the cases, death was related to open surgery. One patient died of meningitis 2 months following stereotactic cyst decompression with insertion of a permanent catheter. Three additional patients died of tumor progression despite early postoperative radiotherapy, whereas one other patient who underwent an incomplete course of radiotherapy at the time of recurrence died of tumor progression. One death occurred as a result of surgery for recurrent tumor. The estimated survival rate on the actuarial survival curve was 92.7% ( Figure 5 ). All deaths related to craniopharyngioma occurred within the first 4 years after surgery. Only one of 73 patients who had complete tumor removal died of the craniopharyngioma during the follow-up period ( Figure 6 ). In contrast, eight patients with incomplete craniopharyngioma removal died of the tumor. Certainly, the lower incidence of mortality after total tumor removal is biased by the smaller size of the craniopharyngiomas removed. The lengths of survival after primary surgery and after surgery for recurrence are compared in Fig. 7 . There was a tendency for the length of survival to be shorter following surgery for tumor recurrence. However, the difference was not statistically significant (p = 0.17, log-rank test). Figure 7 demonstrates that all three disease-related deaths in cases of recurrent craniopharyngiomas were observed within the 1st postoperative year. 
DISCUSSION
Selection of the Operative Approach
In surgical treatment of craniopharyngiomas, basal approaches are most frequently reported because of the predominant location of the tumor in the chiasmatic cistern. Individual neurosurgeon's preferences include the bifrontal interhemispheric approach, [32] the fronto(-lateral) approach, [3, 13] the pterional, [42] and the temporal approach. [36] Via all these approaches, the third ventricle can be entered either through the lamina terminalis [42] or through the basal hypothalamus when using the temporal approach. [36] We now believe that the bifrontal interhemispheric approach is superior to the pterional approach in excising large retrochiasmatic and suprasellar craniopharyngiomas, which can be exposed through the lamina terminalis [15, 32] with a midline view to the interpeduncular cistern. Retrochiasmatic exposure through the lamina terminalis has also been described when using a lateralized frontal approach. [13, 25] In craniopharyngiomas of comparable size, the rate of complete tumor removal is higher when using the bifrontal interhemispheric approach than the pterional. The basal interhemispheric approach also allows a superior view and midline orientation in cases of craniopharyngioma with basal third-ventricle extension. We have learned that exposure of an intrasellar portion through the sphenoid sinus [25] is a crucial technical variant during transcranial procedures. Fifty percent of our recurrences after total removal were encountered within the pituitary fossa which was not exposed through the sphenoid sinus.
Experience with additional surgical approaches is important to deal with the variable locations of craniopharyngiomas and the versatility of the neurosurgeon is mandatory. The selection of the transsphenoidal approach is mandatory for subdiaphragmatic-extraarachnoid craniopharyngiomas. [14, 20] In the literature, the percentage of craniopharygniomas requiring transsphenoidal surgery is up to 39%. [3] The scale of operative approaches is mainly supplemented by the transcallosal or transventricular approach for craniopharyngiomas with upper third ventricle extension and hydrocephalus [40, 42] and by the suboccipital approach for those craniopharyngiomas with major posterior fossa extension. [3, 5] Some craniopharyngiomas can only be removed when using combined approaches. In particular, a superior (transcallosal or transventricular) approach and a basal craniotomy are combined in treating tumors with extension in the intraventricular and extraventricular (intradural) compartments. Yasargil, et al., [42] recommended two approaches to be performed at the same sitting. We performed combined operations with two different operations; these were well tolerated by the patients.
Extent of Tumor Resection
When reviewing the literature, different philosophies are encountered for the surgical management of craniopharyngiomas. Some authors follow a strictly surgical attitude, espousing total tumor removal in all cases. [32, 42] Yasargil, et al., [42] has argued: "The strategy is that of complete tumor removal . . . rather than risking repeated surgical procedures and/or irradiation." This attitude carries the risk of higher rates of early morbidity and mortality. Hoffman and colleagues [13] described their goal as being "total excision of a craniopharyngioma whenever possible" and accomplished total removal in the majority of their cases. They described a risk of postoperative neuropsychological deficits in children. Symon and associates [36] argued that "maximal control of tumour recurrence by removal of all tumour accessible and visible to the surgical microscope is best achieved by a radical excision at the first operation." However, they accepted certain limitations and performed total tumor removal in 30 of 50 cases. We pursue a similar attitude. Initially we attempt total removal of the tumor; however we have to accept subtotal or partial removal if intraoperative findings and events suggest a significant hazard in critical areas. With this attitude, complete tumor removal was accomplished in 45.7% of patients who underwent transcranial operations. Only one (1.1%) of the patients who underwent transcranial surgery died in the early postoperative period and none of the patients in whom complete removal was achieved died. Thus far, only few studies have detailed the intraoperative hazards [18] and the reasons for incomplete tumor removal. [36] In our series, the main problems were tight adherence of tumor to the hypothalamus, major calcifications, and adherence of tumor to vascular structures (Table 5 ) Craniopharyngioma tissue and glial tissue are sometimes intimately connected. [18, 34] The viewpoint not to remove a firmly attached capsule has found support in a recent publication: [7] the authors demonstrated that removal of tumor adherent to the hypothalamus was directly associated with significant occurrence of operative morbidity. A hindered view of some portion of the craniopharyngioma has become a less important problem in our department since the introduction of the bifrontal approach for retrochiasmatic craniopharyngiomas.
Other authors recommend the concept of conservative or limited surgery plus radiotherapy. [9, 28, 29] 
Rates of Mortality and Morbidity
The surgical mortality rate of recent large surgical series is generally between 0% and 4%. [3, 13, 32, 36] The mortality rate of 16.7% in the series of Yasargil, et al., [42] in which the surgeons aggressively performed total removal in all cases is an exception. The question is unresolved as to whether children or adults fare better after surgery. A higher mortality rate has been found in children. [42] In contrast, no instances of mortality or morbidity occurred in our pediatric patients with craniopharyngiomas. In agreement with the literature, [35, 41] our data demonstrate higher rates of mortality and morbidity in surgery for tumor recurrencere.
The mortality rate in patients who undergo transsphenoidal surgery for craniopharyngiomas is generally low. [17, 21] None of our patients died during primary or secondary transsphenoidal surgery. The most frequent complications of this procedure are CSF rhinorrhea and meningitis. [21, 23] Again, we found a lower rate of morbidity in patients undergoing primary surgery.
Our series allowed a direct comparison of transcranial and transsphenoidal procedures with respect to rates of morbidity and mortality. The transsphenoidal operation clearly yields better results. One reason is the extradural nature of infradiaphragmatic craniopharyngiomas. These tumors do not directly encroach on or adhere to intracranial structures. Furthermore, intracranial structures are not directly manipulated during the transsphenoidal approach. Additionally, we could demonstrate a smaller size of infradiaphragmatic craniopharyngiomas suitable for transsphenoidal surgery.
Tumor Recurrence
In modern series, the surgeon's impression of complete tumor removal must be confirmed by sophisticated imaging studies. Today, contrast-enhanced MR imaging is the imaging technique of choice for documenting complete tumor removal. [8, 36] In cases of calcified craniopharyngioma, an additional CT scan should be obtained postoperatively for detection of residual calcifications. Earlier publications on recurrence rates that followed apparently complete tumor removal, which have been extensively reviewed, [29, 30] are no longer applicable to today's surgeries. Hoffman, et al., [13] have demonstrated that residual tumor is relatively often detected during postoperative imaging after what was believed to be a complete tumor removal. This was also experienced by us. With the requirement of postoperative MR imaging and/or CT scanning, only approximately 10 to 17% of totally resected craniopharyngiomas recur, [7, 36, 38] as confrmed by our study.
Recurrence rates dramatically increase if craniopharyngiomas are incompletely removed. [7, 35, 38, 40] Our data impressively demonstrate that freedom from tumor recurrence is closely correlated to the extent of surgical removal. The Kaplan-Meier estimate revealed 10-year recurrence-free survival rates of 83% after total removal, 50.5% after subtotal removal, and 15.6% after partial removal in patients who underwent surgery only. Tumor recurrences mostly occur within the first 5 years [33] and are relatively rare thereafter. [4] The latest instance of recurrence in our series was observed 81 months after surgery.
The recurrence rate is significantly lower in series of patients who underwent transsphenoidal surgery. [19] The recurrence rate after complete removal was 7% in Laws' series [21] of 29 patients with a follow-up review lasting at least 5 years. So far, no recurrence has been encountered in our patients whose craniopharyngiomas were totally removed by transsphenoidal surgery. The different rates of recurrence in cases of infradiaphragmatic and supradiaphragmatic craniopharyngiomas raise the question as to whether these tumors represent different entities among craniopharyngiomas. However, the reasons for the differing long-term results are still unclear.
Functional Outcome
Comparison of surgical outcome with respect to disabilities is virtually impossible because of the heterogeneous criteria for evaluation. Our results demonstrate a high rate of independence without any impairment (77.7%) at the last follow-up examination in patients who underwent primary transcranial surgery. A similar result has been shown by Symon, et al. [36] The degree of postoperative disabilities is quite variable in the literature. The high percentage of postoperative disabilities reported by some authors [7, 9] is discordant with our experience. Even intradural approaches do not necessarily precipitate neuropsychological deficits. We agree with Maira and associates [23] that the most favorable functional results are possible after transsphenoidal surgery.
Survival Rates
With our management of craniopharyngiomas, we found a 10-year actuarial survival rate of 92.7%. Similarly, low numbers of disease-related deaths have been reported in other predominantly surgical series. [7, 13, 36, 38] It is still unclear whether the outcome of surgery is more favorable in children or in adults. In contrast to other series, [42] children in our series fared markedly better than adults. None of our children died during the follow-up period. With the attitude of treating craniopharyngiomas surgically, superior long-term results are anticipated at the expense of early incidences of morbidity and mortality. The risk of delayed disease-related death is considerably higher in patients who undergo less radical operations. [35] Better long-term survival and life expectancy have been documented after radical surgery as opposed to less extensive surgery with or without radiotherapy. [33] Thus far, we have not encountered late mortality in our series.
Radiation Therapy
External Fractionated Radiation Therapy. The efficacy of radiotherapy in the control of craniopharyngiomas has been documented by numerous studies. [10, 24, 29, 31] Recurrence rates after limited or incomplete surgery plus radiotherapy are generally in the range of 25%. [12, 29, 30, 21, 39] Recurrence rates of complete surgical resection using the aforementioned criteria of complete resection compare favorably with results of radiotherapy. On the other hand, patients with partially removed and irradiated craniopharyngiomas are particularly at risk in the long term because the options of further treatment in cases of recurrence are limited. For us, external fractionated radiation therapy is an important adjunct treatment for partially removed or recurrent craniopharyngiomas.
Intracavitary Irradiation.
Intracavitary irradiation is used to treat applied for craniopharyngiomas in specialized centers. [2, 26, 37] It is suitable for purely cystic craniopharyngiomas. However, visual outcome is not satisfactory and treatment failures are fairly frequent. [26, 37] For these reasons, we do not recommend internal irradiation as an initial therapy for patients with craniopharyngiomas.
Stereotactic Radiosurgery. Stereotactic radiosurgery is increasingly used in the management of intracranial tumors. The efficacy of radiosurgery has also been shown in cases of craniopharyngioma. [2, 16, 27] Certainly, radiosurgery is only suitable for use in selected patients: the proximity of most craniopharyngiomas to the optic pathways provides a major limitation to the use of radiosurgery [22] and it is only beneficial in small solid tumors. [16, 22] We believe that the role of radiosurgery in the management of craniopharyngiomas will increase in the near future. It is particularly applicable for treatment of well-defined residual tumor after surgery or treatment of small solid recurrent tumors.
Concept of Surgical Management
The responsibility and burden that lie on the first neurosurgeon to treat the patient and, even more, on the first physician who coordinates further management are heavy. These individuals decide between the options of minimally invasive procedures and radical excision. The former is accompanied by a low rate of morbidity and good short-term results, but a high risk of tumor progression and final loss of quality of life. The latter bears a good chance of cure; however, it is coupled with a more risky early and late operative period and a higher incidence of early morbidity. We recommend radical surgery as the initial therapy of choice in patients with craniopharyngioma. The goal of therapy should be selective removal of the tumor with preservation, either directly of indirectly, of all functionally important structures, (that is, the hypothalamus, midbrain, perforating vessels of the circle of Willis, optic chiasm, pituitary stalk, and pituitary gland). This can only be achieved if the skills for all possible operative approaches can be offered to the patients. Ideally, all approaches are available within the same institution; they have to be tailored to tumor extension and to the patient's general condition. This concept offers the option of radical excision with a chance of long-term freedom from tumor recurrence. Apart from surgical experience, special expertise in the perioperative management of endocrine and vegetative dysfunctions of the hypothalamus is required in those selected centers that treat craniopharyngiomas surgically.
Only in the presence of severe risk factors and hypothalamic dysregulation, should limited surgery (stereotactic cyst decompression and/or shunt implantation) be performed. In all other cases, primary surgery should attempt total tumor removal. In the presence of a large cystic portion of tumor, stereotactic cyst decompression may precede direct tumor removal. However, the surgeon should accept subtotal or partial tumor removal if intraoperative findings suggest that complete removal can only be accomplished with a significant chance of morbidity or mortality. With this policy, our 10-year survival rate was better in patients who had complete tumor removal. This result demonstrates that intraoperative hazards can be recognized and avoided. In patients in whom the craniopharyngioma has been totally removed, a high rate of definite cure is anticipated. Even if a recurrence occurs, the whole scale of therapeutic options is still available. In patients in whom the craniopharyngioma has been subtotally removed, there is also a 50% chance of recurrence-free survival. Therefore, radiotherapy should also be deferred in this subgroup of patients. We have learned that only partially removed craniopharyngiomas are most likely to recur and would, therefore, recommend early postoperative radiotherapy in patients after partial tumor removal.
Tumor recurrence should be treated by additional surgery if a chance of significant reduction in tumor size appears likely. Recurrent cysts are frequently decompressed stereotactically. Recurrent craniopharyngiomas that cannot be totally removed should be additionally treated with fractionated external radiation therapy or radiosurgery.
The future surgical management of craniopharyngiomas could be influenced by additional progress in the fields of preoperative diagnosis and intraoperative and postoperative management. Preoperatively, improvements in imaging of peritumoral structures could be helpful to demonstrate the displaced hypothalamus with its nuclei and the third ventricle in relation to the precise location of tumor attachment. It remains to be seen how much the surgeon can benefit by introduction of intraoperative endoscopy, neuronavigation, and intraoperative resection control by MR imaging. This could improve the extent of resection but also demonstrates the limitations of surgical resection. On the basis of our present knowledge of hypothalamic functions in humans, possibilities of functional monitoring of the hypothalamus, which could guide surgical maneuvers, are not anticipated. New aspects of predicting outcome could arise from histopathological examinations [1, 6] and molecular biolological studies.
